BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1231 related articles for article (PubMed ID: 28231720)

  • 1. Tumor-associated macrophages: implications in cancer immunotherapy.
    Petty AJ; Yang Y
    Immunotherapy; 2017 Mar; 9(3):289-302. PubMed ID: 28231720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Associated Macrophages as Target for Antitumor Therapy.
    Sawa-Wejksza K; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):97-111. PubMed ID: 28660349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies.
    Zhu C; Kros JM; Cheng C; Mustafa D
    Neuro Oncol; 2017 Oct; 19(11):1435-1446. PubMed ID: 28575312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
    Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
    Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma.
    Degroote H; Van Dierendonck A; Geerts A; Van Vlierberghe H; Devisscher L
    J Immunol Res; 2018; 2018():7819520. PubMed ID: 30410942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated macrophages: role in cancer development and therapeutic implications.
    Salmaninejad A; Valilou SF; Soltani A; Ahmadi S; Abarghan YJ; Rosengren RJ; Sahebkar A
    Cell Oncol (Dordr); 2019 Oct; 42(5):591-608. PubMed ID: 31144271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis.
    Dirkx AE; Oude Egbrink MG; Wagstaff J; Griffioen AW
    J Leukoc Biol; 2006 Dec; 80(6):1183-96. PubMed ID: 16997855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
    Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
    Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis.
    Fu LQ; Du WL; Cai MH; Yao JY; Zhao YY; Mou XZ
    Cell Immunol; 2020 Jul; 353():104119. PubMed ID: 32446032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers.
    Kielbassa K; Vegna S; Ramirez C; Akkari L
    Front Immunol; 2019; 10():2215. PubMed ID: 31611871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
    Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
    Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tumor-associated macrophages in tumor immune evasion.
    Huang R; Kang T; Chen S
    J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
    Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
    Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
    Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tumor-associated macrophages for cancer immunotherapy.
    Shu Y; Cheng P
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing.
    Zins K; Abraham D
    Methods Mol Biol; 2020; 2115():289-325. PubMed ID: 32006408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages: Key orchestrators of a tumor microenvironment defined by therapeutic resistance.
    Long KB; Collier AI; Beatty GL
    Mol Immunol; 2019 Jun; 110():3-12. PubMed ID: 29273393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.
    Tariq M; Zhang J; Liang G; Ding L; He Q; Yang B
    J Cell Biochem; 2017 Sep; 118(9):2484-2501. PubMed ID: 28106295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.